We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceuticals Inc., a privately held company based in Kendall Park, New Jersey, announced that it has obtained a worldwide license from Institute of Microbial Technology (IMTECH), Chandigarh, India, to carry out clinical development and commercialization of a novel clot busting therapeutic protein.
Merck & Co Inc's Gardasil, the first vaccine to prevent cervical cancer, was endorsed by a panel of European experts on Friday, bringing mass vaccination against the killer disease a step nearer.
Barr Pharmaceuticals, Inc. announced that its European subsidiary has officially filed a tender offer with the Croatian Financial Services Supervisory Agency (HANFA) to purchase 100% of the shares of PLIVA d.d., based in Zagreb, Croatia.
Agents for the Federal Bureau of Investigation raided the office of Bristol-Myers Squibb Co. Chief Executive Peter Dolan as part of a criminal antitrust probe, The Wall Street Journal reported on Friday, citing a person familiar with the matter.
GlaxoSmithKline (GSK) has announced an agreement with the U.S. government to provide a stockpile of its anti-viral drug in preparation for a potential influenza pandemic.
The maker of a wound lotion that it claims to relieve pain for those suffering from wounds associated with diabetes is in violation of the law for selling unapproved drugs, the FDA said in a warning letter posted July 19.
The biotech industry got a partial victory in its efforts to allow more venture capital-backed firms to receive research funding when compromise legislative language passed out of committee July 27.